Peak Retirement Planning Inc. Raises Holdings in Merit Medical Systems, Inc. $MMSI

Peak Retirement Planning Inc. lifted its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 35.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,472 shares of the medical instruments supplier’s stock after purchasing an additional 8,494 shares during the period. Merit Medical Systems comprises approximately 0.7% of Peak Retirement Planning Inc.’s holdings, making the stock its 28th biggest holding. Peak Retirement Planning Inc. owned 0.05% of Merit Medical Systems worth $2,862,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the business. Tudor Investment Corp ET AL purchased a new position in shares of Merit Medical Systems during the 3rd quarter worth approximately $2,913,050,000. State Street Corp increased its stake in shares of Merit Medical Systems by 1.1% during the 2nd quarter. State Street Corp now owns 2,218,432 shares of the medical instruments supplier’s stock worth $207,379,000 after purchasing an additional 24,569 shares in the last quarter. Wellington Management Group LLP increased its stake in shares of Merit Medical Systems by 377.7% during the 3rd quarter. Wellington Management Group LLP now owns 1,240,509 shares of the medical instruments supplier’s stock worth $103,248,000 after purchasing an additional 980,823 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Merit Medical Systems by 6.2% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,177,862 shares of the medical instruments supplier’s stock worth $98,021,000 after purchasing an additional 68,711 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Merit Medical Systems by 7.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 917,122 shares of the medical instruments supplier’s stock worth $76,332,000 after purchasing an additional 64,920 shares in the last quarter. 99.66% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Merit Medical Systems

In other news, Director Lynne N. Ward sold 5,000 shares of the business’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $62.61, for a total transaction of $313,050.00. Following the completion of the sale, the director directly owned 7,809 shares of the company’s stock, valued at $488,921.49. The trade was a 39.04% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Brian G. Lloyd acquired 2,000 shares of the stock in a transaction dated Thursday, May 7th. The shares were bought at an average cost of $62.62 per share, with a total value of $125,240.00. Following the completion of the purchase, the insider directly owned 2,000 shares in the company, valued at approximately $125,240. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.70% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on MMSI shares. Weiss Ratings cut shares of Merit Medical Systems from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, May 8th. Piper Sandler lowered their target price on shares of Merit Medical Systems from $106.00 to $96.00 and set an “overweight” rating for the company in a research note on Friday, April 17th. Barrington Research lowered their target price on shares of Merit Medical Systems from $109.00 to $107.00 and set an “outperform” rating for the company in a research note on Monday, April 20th. Compass Point set a $107.00 target price on shares of Merit Medical Systems in a research note on Monday, April 20th. Finally, Needham & Company LLC lowered their target price on shares of Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating for the company in a research note on Friday, May 1st. Eight research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Merit Medical Systems has a consensus rating of “Moderate Buy” and an average price target of $92.80.

Merit Medical Systems Stock Down 1.9%

MMSI stock opened at $60.89 on Wednesday. The stock has a market capitalization of $3.63 billion, a P/E ratio of 26.36, a PEG ratio of 1.93 and a beta of 0.54. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.46 and a current ratio of 5.08. Merit Medical Systems, Inc. has a one year low of $59.74 and a one year high of $96.74. The company has a 50 day moving average price of $66.18 and a two-hundred day moving average price of $76.68.

Merit Medical Systems (NASDAQ:MMSI) last released its earnings results on Thursday, April 30th. The medical instruments supplier reported $0.94 EPS for the quarter, topping the consensus estimate of $0.84 by $0.10. Merit Medical Systems had a net margin of 9.03% and a return on equity of 13.54%. The firm had revenue of $381.88 million during the quarter, compared to analysts’ expectations of $377.59 million. During the same period in the previous year, the company earned $0.86 EPS. Merit Medical Systems’s revenue for the quarter was up 7.4% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. As a group, sell-side analysts expect that Merit Medical Systems, Inc. will post 3.62 EPS for the current year.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.